• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares (NQ:LSE)

4.600 -0.070 (-1.50%)
Streaming Delayed Price Updated: 9:51 AM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis
February 24, 2026
From Avacta Group PLC
Via GlobeNewswire
News headline image
Leishen Energy Holding Co., Ltd. Announced Fiscal Year 2025 Financial Results Highlighting Strong Operating Cash Flow and Low Financial Leverage
February 15, 2026
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
News headline image
Corero Network Security to Present at the AI & Technology Virtual Investor Conference February 19th
February 13, 2026
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Avacta appoints Francis Wilson as Chief Scientific Officer
February 09, 2026
From Avacta Group PLC
Via GlobeNewswire
News headline image
HUTCHMED to Announce 2025 Final Results
February 06, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
February 03, 2026
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase price 
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program
February 03, 2026
Cardiac dosing limit removed and path forward to dose selection identified 
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
Interim Results for the six months ended 31 October 2025
January 29, 2026
From Scancell Holdings Plc
Via GlobeNewswire
News headline image
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
January 26, 2026
From Scancell Holdings Plc
Via GlobeNewswire
News headline image
Leishen Energy Holding Co., Ltd. Announces Receipt of Nasdaq Notice Regarding Annual Meeting Requirement
January 23, 2026
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
News headline image
Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)
January 21, 2026
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
Avacta Announces Year-end Trading Update
January 20, 2026
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
January 13, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
January 06, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
January 04, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
December 30, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma
December 29, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
December 23, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Zimbabwe government amends proposed changes to the royalty and tax regimes
December 19, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
December 17, 2025
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors
December 16, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
December 16, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder
December 10, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+ in patients with first line advanced melanoma
December 09, 2025
From Scancell Holdings Plc
Via GlobeNewswire
News headline image
HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China
December 07, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Empire to Present at the Precious Metals & Critical Minerals Virtual Investor Conference
December 01, 2025
From Virtual Investor Conferences; Empire Metals Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Proposed Changes to Royalty and Tax Regimes in Zimbabwe
December 01, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Reminder of Remote Presentation on Publication of Feasibility Study for Bilboes Gold Project in Zimbabwe
November 28, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
November 26, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Publication and Highlights of the Feasibility Study for Bilboes Gold Project
November 25, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap